1. Paroxysmal Atrioventricular Block in a Relatively Young Patient with COVID-19
- Author
-
Sayuri Kataoka, Kentaro Nakamura, Yoshikatsu Gima, Masami Abe, Akiko Matsuzaki, Naoto Miyagi, Chikashi Nago, Suguru Chiba, Masakazu Nakae, Sho Hatano, Toshiya Chinen, and Hiroki Uehara
- Subjects
Bradycardia ,Adult ,Male ,medicine.medical_specialty ,Pacemaker, Artificial ,Coronavirus disease 2019 (COVID-19) ,Cardiac biomarkers ,030204 cardiovascular system & hematology ,medicine.disease_cause ,03 medical and health sciences ,0302 clinical medicine ,Cardiac magnetic resonance imaging ,Internal medicine ,Internal Medicine ,medicine ,Humans ,Atrioventricular Block ,Coronavirus ,medicine.diagnostic_test ,business.industry ,SARS-CoV-2 ,Paroxysmal Atrioventricular Block ,COVID-19 ,General Medicine ,medicine.disease ,cardiovascular system ,Cardiology ,030211 gastroenterology & hepatology ,Myocardial fibrosis ,medicine.symptom ,business ,Cardiomyopathies ,Atrioventricular block - Abstract
Cardiac involvement has been reported in patients with coronavirus disease 2019 (COVID-19). We herein report a 41-year-old man who presented with recurrent paroxysmal atrioventricular block without showing significant cardiac injuries or comorbidities. The patient was diagnosed with COVID-19 and admitted to our hospital, where he was noted to have paroxysmal atrioventricular block. Cardiac biomarkers, echocardiography, and cardiac magnetic resonance imaging findings were fairly normal. An endomyocardial biopsy performed before the implantation of a permanent pacemaker revealed mild myocardial fibrosis without inflammatory infiltrates. The unusual myocardial involvement of the novel coronavirus was suspected.
- Published
- 2021